Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for AKRX

Data valid for week beginning January 05, 2009

Ticker Company Name
AKRX   [News] Akorn Inc
Company Profile
"Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in areas, such as ophthalmology, rheumatology, anesthesia, and antidotes primarily in the United States. The company operates in four segments: Ophthalmic, Hospital Drugs and Injectables, Biologics and Vaccines, and Contract Services. The Ophthalmic segment offers a line of diagnostic and therapeutic ophthalmic pharmaceutical products. Its diagnostic products include mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are primarily used in the office setting. This segment’s therapeutic products comprise antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants-antihistamines, and anti-edema medications. Its non-pharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The Hospital Drugs and Injectables segment provides a line of injectable pharmaceutical products, including antidotes, anesthesia, and products used in the treatment of rheumatoid arthritis and pain management. These products are marketed to hospitals through wholesalers and other national account customers, as well as directly to medical specialists. The Biologics and Vaccines segment offers adult Tetanus-Diphtheria vaccines, which are marketed directly to hospitals and physicians, as well as through wholesalers and national distributors. The Contract Services segment manufactures products for third party pharmaceutical and biotechnology customers. The company serves physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and pharmaceutical companies. It has strategic partnerships with Strides Arcolab Limited- Serum Institute of India, Ltd.- Hameln Pharmaceuticals- and Cipla, Ltd. Akorn, Inc. was founded in 1971 and is headquartered in Buffalo Grove, Illinois."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

AKRX Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for AKRX. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Akorn Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $2.64
Volume Avg. 360420 shares
Industry Diagnostic Substances
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin -13.44%
Operating Margin -13.16%
Debt-to-Equity .25%
P/E ttm 0.00
EPS ttm $-0.120
EBITDA $-6,110,000
Total Revenue $81,270,000
Market Cap $158,080
Annual Dividend $.00
Yield .000%
ROE -17.79%
Revenue Growth Rate Quarterly 101.60%
Earnings Growth Rate Quarterly 150.80%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 0.57%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Fri, 2 Jan 2009 15:47:00 Etc/GMTPowerRatings Weekly Recap: GPRO, RGLD, TEVA, CEPH (TradingMarkets.com)
Wed, 31 Dec 2008 14:23:43 Etc/GMTUPDATE - Akorn-Strides gets FDA nod for two generic antibiotics (at Reuters)
Wed, 31 Dec 2008 13:28:19 Etc/GMTAkorn's generic antibiotic approved by FDA (AP)
Wed, 31 Dec 2008 12:00:00 Etc/GMTAkorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package (Business Wire)
Tue, 30 Dec 2008 14:29:10 Etc/GMTHedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008 (at Seeking Alpha)
Tue, 23 Dec 2008 22:32:32 Etc/GMTBiovail settles lawsuits with ex-analyst Treppel (AP)
Tue, 16 Dec 2008 12:00:00 Etc/GMTAkorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl (Business Wire)
Fri, 12 Dec 2008 14:01:48 Etc/GMTFDA approves generic drug application from Akorn (AP)
Fri, 12 Dec 2008 12:00:00 Etc/GMTAkorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3% (Business Wire)
Mon, 24 Nov 2008 21:25:12 Etc/GMTInvesting in India's Generic Drug Market (at Seeking Alpha)
Mon, 24 Nov 2008 20:13:48 Etc/GMTAkorn, Bioluz team up to produce, market drugs (AP)
Mon, 24 Nov 2008 12:00:00 Etc/GMTAkorn, Inc. Signs Memorandum of Understanding with Bioluz S.A. for Five Premix Products (Business Wire)
Thu, 20 Nov 2008 12:00:00 Etc/GMTAkorn Enters into a Five Year Contract Manufacturing Agreement to Supply an Ophthalmic Product (Business Wire)
Wed, 19 Nov 2008 14:04:16 Etc/GMTAKORN INC Financials (EDGAR Online Financials)
Tue, 18 Nov 2008 10:01:29 Etc/GMTAkorn, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha)
Mon, 10 Nov 2008 22:12:55 Etc/GMTAKORN INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Thu, 6 Nov 2008 12:00:00 Etc/GMTAkorn, Inc. to Present at the Credit Suisse Healthcare Conference (Business Wire)
Wed, 5 Nov 2008 11:01:14 Etc/GMTAKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online)
Tue, 4 Nov 2008 14:24:54 Etc/GMTNew Star Analyst Rankings for AKORN INC (StarMine)
Tue, 4 Nov 2008 11:01:04 Etc/GMTAKORN INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)
News provided by Yahoo! Finance